These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16929569

  • 1. Policy currents. FDA addresses backlog of generic medication applications.
    Consult Pharm; 2006 May; 21(5):419-21. PubMed ID: 16929569
    [No Abstract] [Full Text] [Related]

  • 2. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2008 Sep 29; 73(189):56487-91. PubMed ID: 18985960
    [Abstract] [Full Text] [Related]

  • 3. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M.
    N Engl J Med; 2007 Apr 26; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract] [Full Text] [Related]

  • 4. What ails the FDA?
    Okie S.
    N Engl J Med; 2005 Mar 17; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract] [Full Text] [Related]

  • 5. Biogenerics standoff.
    Herrera S.
    Nat Biotechnol; 2004 Nov 17; 22(11):1343-6. PubMed ID: 15529145
    [No Abstract] [Full Text] [Related]

  • 6. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL.
    Food Drug Law J; 2005 Nov 17; 60(2):261-338. PubMed ID: 16094773
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR.
    Suffolk Univ Law Rev; 2003 Nov 17; 36(3):787-819. PubMed ID: 16493844
    [No Abstract] [Full Text] [Related]

  • 9. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Jul 28; 74(143):37163-8. PubMed ID: 19655468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Oct 18; 72(201):58993-9000. PubMed ID: 17966558
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ensuring the safety of genotech drugs through implied warranty theory.
    Serra WM.
    Am J Law Med; 1997 Oct 18; 23(2-3):363-81. PubMed ID: 9262761
    [No Abstract] [Full Text] [Related]

  • 16. The FDA and drug safety: a proposal for sweeping changes.
    Furberg CD, Levin AA, Gross PA, Shapiro RS, Strom BL.
    Arch Intern Med; 2006 Oct 09; 166(18):1938-42. PubMed ID: 17030825
    [Abstract] [Full Text] [Related]

  • 17. Blowing the whistle at the FDA.
    Simons J.
    Fortune; 2005 Jan 24; 151(2):32. PubMed ID: 15693304
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.